non-small cell lung cancer Clinical Trials and Research
Also known as: nsclc, lung adenocarcinoma, squamous cell lung cancer, large cell carcinoma, non-small cell lung carcinoma, lung cancer · ICD-10: C34
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Clinical trial research is actively exploring new targeted therapies, immunotherapies, and improved detection methods to enhance patient outcomes. Find a Trial helps patients search for active studies for NSCLC.
Search non-small cell lung cancer trials →
Common questions about non-small cell lung cancer clinical trials
What are the different phases of NSCLC clinical trials?
Clinical trials for NSCLC typically progress through phases 1, 2, and 3. Phase 1 studies focus on safety, phase 2 on effectiveness, and phase 3 compare new treatments to existing ones, as documented on ClinicalTrials.gov.
What new treatments are being studied for non-small cell lung cancer?
Active research for NSCLC includes studies on novel targeted therapies that block specific cancer growth pathways, and various immunotherapies that boost the body's own immune response. Data from NIH RePORTER and ClinicalTrials.gov highlight these innovative approaches.
Are there specific biomarkers important in NSCLC clinical trials?
Yes, biomarkers like EGFR mutations, ALK rearrangements, and PD-L1 expression are crucial in NSCLC trials. These markers help identify patients who might respond to specific targeted or immunotherapies, as shown in studies on ClinicalTrials.gov.
Do NSCLC clinical trials cost money to participate?
Generally, the investigational treatment and study-related tests are covered by the trial sponsor. However, routine medical care costs may still be the participant's responsibility, as outlined in study protocols on ClinicalTrials.gov.
What types of interventions are common in NSCLC clinical trials?
Common interventions include new drug therapies (e.g., targeted agents, immunotherapies), novel radiation techniques, and surgical approaches. Some trials also explore combinations of these treatments, according to ClinicalTrials.gov.
What are common reasons someone might be excluded from an NSCLC trial?
Common exclusion criteria can include uncontrolled co-existing medical conditions, prior treatments that might interfere with the study drug, or certain types of brain metastases. These are designed to ensure patient safety, as detailed on ClinicalTrials.gov.
Are there clinical trials focused on early detection of NSCLC?
Yes, some clinical trials are investigating new methods for earlier detection of NSCLC, such as advanced imaging techniques or liquid biopsies. The goal is to find cancer at a more treatable stage, as seen on NIH RePORTER.
How to find a non-small cell lung cancer trial that fits you
- Describe your non-small cell lung cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all non-small cell lung cancer trials →